CTOs on the Move

Prometheus Laboratories

www.prometheuslabs.com

 
Prometheus Laboratories Inc. is one of the leading companies in the Healthcare, Pharmaceuticals and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Industrial Pharmaceutical Resources

Industrial Pharmaceutical Resources, Inc. is a Bartlett, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corepharma LLC

Corepharma LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Syros

Syros Pharmaceuticals is pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of disease-driving genes. Syros has built a proprietary platform that is designed to systematically and efficiently analyze this unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations. Because gene expression is fundamental to the function of all cells, the Company’s gene control platform has broad potential to achieve profound and durable benefit across a range of diseases. Syros is focused on cancer and immune-mediated diseases and is advancing a growing pipeline, including its lead drug candidates SY-1425, a selective RARα agonist for genomically defined subsets of patients identified by its platform, for a range of cancers including acute myeloid leukemia and myelodysplastic syndrome, and SY-1365, a selective CDK7 inhibitor for a range of blood cancers and solid tumors. Led by a team with deep experience in drug discovery, development and commercialization, Syros is located in Cambridge, Mass.

Orexigen

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Orexigen developed Contrave® (naltrexone HCl and bupropion HCl extended release), which is approved in the United States and is being commercialized there by the company`s North American partner, Takeda Pharmaceuticals. In Europe the drug has been approved under the brand name Mysimba™ (naltrexone HCl/ bupropion HCl prolonged release). Orexigen`s strategy for Contrave/ Mysimba is to pursue marketing authorizations worldwide and pharmaceutical partnerships for global commercialization.

U.S MAX HEALING PRODUCTS,INC

U.S MAX HEALING PRODUCTS,INC is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.